On Monday, Vor Biopharma Inc (NASDAQ: VOR) opened lower -7.24% from the last session, before settling in for the closing price of $2.21. Price fluctuations for VOR have ranged from $0.13 to $3.29 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -38.02%. Company’s average yearly earnings per share was noted 56.45% at the time writing. With a float of $64.90 million, this company’s outstanding shares have now reached $124.85 million.
The extent of productivity of a business whose workforce counts for 159 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Vor Biopharma Inc (VOR) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Vor Biopharma Inc is 48.06%, while institutional ownership is 42.13%. The most recent insider transaction that took place on Jul 16 ’25, was worth 415,391. Before that another transaction happened on Jul 15 ’25, when Company’s Officer proposed sale 214,135 for $2.43, making the entire transaction worth $520,586.
Vor Biopharma Inc (VOR) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 56.45% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.66% during the next five years compared to -38.02% drop over the previous five years of trading.
Vor Biopharma Inc (NASDAQ: VOR) Trading Performance Indicators
Check out the current performance indicators for Vor Biopharma Inc (VOR). In the past quarter, the stock posted a quick ratio of 3.88.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.51, a number that is poised to hit -0.44 in the next quarter and is forecasted to reach -0.47 in one year’s time.
Technical Analysis of Vor Biopharma Inc (VOR)
The latest stats from [Vor Biopharma Inc, VOR] show that its last 5-days average volume of 8.99 million was superior to 8.44 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 22.19%.
During the past 100 days, Vor Biopharma Inc’s (VOR) raw stochastic average was set at 60.75%, which indicates a significant increase from 35.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.53 in the past 14 days, which was higher than the 0.14 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.82, while its 200-day Moving Average is $0.92.
